LRRK2 and Parkinson disease: Here we present data from an integrated proteomic and transcriptomic analysis of induced-pluripotent stem cell (iPSC)-derived dopaminergic cultures from PD patients carrying the LRRK2-G2019S mutation, which reveals dysregulation of endocytosis in these cells.